Roche’s Virtual Event following ASH 2020

Tuesday, 8 December 2020, 16:00 CET

Additional information

Invitation

Related links

Presentations from recent IR events

Investor updates

Published on: 2 December 2020

Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers

Published on: 2 December 2020

Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies

Published on: 1 December 2020

FDA approves Xolair® (omalizumab) for adults with nasal polyps

IR events

8December

Roche’s virtual event on key hematology data presented at ASH

(EST)

Orlando, US

more add to calendar

11January

J.P. Morgan 39th Annual Healthcare Conference (virtual event)

(PST)

San Francisco, US

add to calendar

14January

Octavian Seminar 2020 (virtual event)

(CET)

Zurich, Switzerland

add to calendar

Share price

Latest annual report

Annual Report 2019 Highlights

How medicines are making an impact in the lives of patients

Finance information tool

Pipeline

Pipeline

Get up-to-date information about our pipeline.

Roche R&D

Genentech Biooncology

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

Diagnostics news

Sustainability

Sustainability download center

Sustainability at Roche

Non-financial reporting

Dividend and total return

Dividend calendar

Timetable for the payment of the 2019 dividend

Total return center

Investor tool providing analysis of total returns

Frequently asked questions

FAQ

Get answers to frequently asked questions

US investors

How to invest

Contact